文献速递消化道肿瘤放疗放疗物理与技术

直肠癌调强放疗中小肠运动评估及腹膜腔替代肠管剂量约束的可行性

Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer.
PubMed 文献 · Radiat Oncol · 2020-09-01

本研究纳入24例接受辅助或新辅助放疗的直肠癌患者,每周重复CT扫描至第4周,评估小肠运动,并探索用腹膜腔(PS)替代肠管(BL)进行剂量约束的可行性。结果显示BL运动显著大于PS,俯卧位显著小于仰卧位;用PS替代BL保护小肠可行,V15<830 cc为剂量约束标准。

要点

  • 直肠癌调强放疗中小肠运动可导致剂量体积和NTCP评估的不确定性。
  • BL的运动显著大于PS,俯卧位显著小于仰卧位。
  • 用PS替代BL保护小肠可行,V15<830 cc为剂量约束标准。

核心结论

  • 小肠运动可能导致直肠癌调强放疗中剂量体积和NTCP评估的不确定性。
  • BL运动显著大于PS,俯卧位显著小于仰卧位。
  • 用PS替代BL保护小肠可行,V15<830 cc为剂量约束标准。

研究设计与样本

  • 选取24例接受辅助或新辅助放疗的直肠癌患者。
  • 从治疗前至治疗第4周每周重复CT扫描,定义为Plan、1W、2W、3W、4W。
  • 将4次每周CT扫描与Plan CT配准,勾画BL和PS轮廓。
  • 在Plan CT上使用PS约束方法设计IMRT计划,然后复制到4次每周CT扫描。
  • 评估小肠的剂量体积、正常组织并发症概率(NTCP)及其治疗期间的变化。

主要发现

  • 共获取24例患者的109套CT扫描,设计并复制109个计划。
  • BL和PS体积分别为250.3 cc和1339.3 cc。
  • 治疗前基于BL和PS计划的V15分别为182.6 cc和919.0 cc,治疗期间偏移百分比分别为28.9%和11.3%(p=0.000)。
  • 俯卧位偏移小于仰卧位(25.2% vs 32.1%,p=0.000;9.9% vs 14.9%,p=0.000)。
  • 治疗前基于计划的NTCPC和NTCPA分别为2.0%和59.2%,治疗期间偏移百分比分别为46.1%和14.0%。

关键数值与推荐

  • 使用PS剂量限制方法时,治疗期间多数BL的Dmax和V15符合安全标准,除外V15的3次(3/109)和Dmax的5次(5/109)。
  • V15<830 cc为剂量约束标准。

临床怎么用

  • 在直肠癌调强放疗中可考虑用腹膜腔(PS)替代肠管(BL)进行剂量约束以保护小肠。
  • 采用V15<830 cc作为剂量约束标准。
  • 俯卧位可能减少小肠运动带来的剂量不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The goal of this study was to assess small bowel motion and explore the feasibility of using peritoneal space (PS) to replace bowel loops (BL) via the dose constraint method to spare the small bowel during intensity-modulated radiotherapy (IMRT) for rectal cancer. METHODS: A total of 24 patients with rectal cancer who underwent adjuvant or neoadjuvant radiotherapy were selected. Weekly repeat CT scans from pre-treatment to the fourth week of treatment were acquired and defined as Plan, 1 W, 2 W, 3 W, and 4 W. The 4 weekly CT scans were co-registered to the Plan CT, BL and PS contours were delineated in all of the scans, an IMRT plan was designed on Plan CT using PS constraint method, and then copied to the 4 weekly CT scans. The dose-volume, normal tissue complication probability (NTCP) of the small bowel and their variations during treatment were evaluated. RESULTS: Overall, 109 sets of CT scans from 24 patients were acquired, and 109 plans were designed and copied. The BL and PS volumes were 250.3 cc and 1339.3 cc. The V15 of BL and PS based plan of pre-treatment were 182.6 cc and 919.0 cc, the shift% of them were 28.9 and 11.3% during treatment (p = 0.000), which was less in the prone position than in the supine position (25.2% vs 32.1%, p = 0.000; 9.9% vs 14.9%, p = 0.000). The NTCPC and NTCPA based plan of pre-treatment were 2.0 and 59.2%, the shift% during treatment were 46.1 and 14.0% respectively. Majority of BL's Dmax and V15 were meet the safety standard during treatment using PS dose limit method except 3 times (3/109) of V15 and 5 times of Dmax (5/109). CONCLUSIONS: This study indicated that small bowel motion may lead to uncertainties in its dose volume and NTCP evaluation during IMRT for rectal cancer. The BL movements were significantly greater than PS, and the prone position was significantly less than the supine position. It is feasibility of using PS to replace BL to spare the small bowel, V15 < 830 cc is the dose constraint standard.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li S, Gong Y, Yang Y, et al. Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer. Radiat Oncol. 2020. PMID: 32873308. doi:10.1186/s13014-020-01650-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。